Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.47
+0.21 (2.26%)
Jul 31, 2025, 12:25 PM - Market open
CRBP's stock price has decreased by -84.2% in the past year and price targets may not have had time to catch up.
CRBP Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$53.56
Upside
+465.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $65 → $58 | Buy | Maintains | $65 → $58 | +512.53% | May 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $56 | Buy | Maintains | $60 → $56 | +491.40% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +322.43% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 → $50 | Strong Buy | Reiterates | $75 → $50 | +428.04% | Mar 12, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $70 → $53 | Strong Buy | Maintains | $70 → $53 | +459.72% | Mar 11, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +692.06% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 → $75 | Strong Buy | Reiterates | $80 → $75 | +692.06% | Feb 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $35 | Buy | Initiates | $35 | +269.63% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +744.86% | Sep 23, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $85 → $40 | Strong Buy | Maintains | $85 → $40 | +322.43% | Sep 20, 2024 |
| Wedbush | Wedbush | Buy Maintains $85 → $51 | Buy | Maintains | $85 → $51 | +438.60% | Sep 20, 2024 |
| Mizuho | Mizuho | Buy Reiterates $74 | Buy | Reiterates | $74 | +681.50% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +765.98% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +765.98% | Aug 28, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +765.98% | Aug 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.